Esterase D (ESD), encoded by the ESD gene, is a serine hydrolase enzyme with diverse biological roles, including detoxification, drug metabolism, and genetic marker applications . It is a dimeric protein with a molecular mass of 33–34 kDa, primarily expressed in liver, kidney, and erythrocytes . ESD catalyzes the hydrolysis of ester bonds in substrates such as 4-methylumbelliferyl acetate (K<sub>m</sub> = 10 µM) and O-acetylated sialic acids . Its genetic locus on chromosome 13q14.11 makes it a critical marker for retinoblastoma and Wilson’s disease .
Detoxification: Hydrolyzes ester-containing toxins and drugs, modulating cellular responses to environmental stressors .
Sialic Acid Recycling: Proposed role in O-acetyl ester hydrolysis, though distinct from other esterases like esterase X .
Genetic Regulation: Phenobarbital induces ESD expression 3-fold in promonocytic cells, suggesting a role in detoxification pathways .
Allele | Molecular Mass | Specific Activity | pI | Notes |
---|---|---|---|---|
ESD<sup>1</sup> | 33–34 kDa | High | Neutral | Wild-type allele |
ESD<sup>7</sup> | Slightly smaller | Low | Neutral | Molecular weight variant with reduced enzymatic activity |
ESD<sup>7</sup> Polymorphism: A rare allele producing a subunit with lower specific activity but similar pI to ESD<sup>1</sup> .
Disease Association:
Recent studies highlight ESD’s role in modulating cancer cell proliferation:
FPD5 Activation: A small-molecule activator of ESD (FPD5) induces nuclear accumulation of p53 in A549 lung cancer cells, inhibiting cell cycle progression .
JAB1/p53 Regulation: ESD disrupts JAB1-mediated p53 degradation, stabilizing nuclear p53 and suppressing cell cycle regulators CDCA8 and CDC20 .
Cell Cycle Arrest: FPD5-treated A549 cells show G0/G1 phase arrest, with reduced CDCA8 (log<sub>2</sub> ratio = −1.50) and CDC20 (log<sub>2</sub> ratio = −1.74) expression .
Human Esterase D (ESD, EC 3.1.1.1) is a serine hydrolase that belongs to the esterase D family. This carboxylesterase is encoded by the ESD gene located on chromosome 13 and functions as a carboxylic-ester hydrolase . Biochemically, ESD demonstrates activity toward numerous substrates, particularly O-acetylated compounds, reflecting its broad substrate specificity .
The enzyme plays a significant role in detoxification processes, particularly in the liver and kidney where it is highly expressed . This hypothesis is supported by research showing that ESD expression can be enhanced approximately 3-fold in promonocytic cell lines when treated with phenobarbital, a known inducer of detoxification enzymes . Interestingly, the enzyme does not show increased expression when treated with phorbol myristate acetate, suggesting specificity in its regulatory pathways .
Research indicates that ESD functions primarily as a detoxification enzyme, metabolizing various xenobiotics and endogenous compounds by hydrolyzing ester bonds. Its high conservation across mammalian species further suggests an essential biological role that has been maintained throughout evolution .
Human Esterase D has been purified to biochemical homogeneity from erythrocytes, revealing several key structural and kinetic properties. The enzyme exists as a protein with a molecular mass of approximately 33-34 kDa . Importantly, ESD exists in multiple forms in vivo, functioning as both homodimeric and heterodimeric structures that contribute to the observed polymorphism in human populations .
Kinetically, the enzyme demonstrates a Km value of approximately 10 × 10^-6 M when using 4-methylumbelliferyl acetate as a substrate . This relatively low Km value indicates a high affinity for this particular substrate. The enzymatic activity is notably inhibited by p-chloromercuribenzoate and HgCl2, strongly suggesting that sulfhydryl (SH) groups play a critical role in the enzyme's catalytic function .
Two-dimensional isoelectric focusing methods have been developed specifically to identify the ESD subunits from both homodimeric and heterodimeric forms across five different ESD phenotypes . These techniques have been instrumental in understanding the enzyme's quaternary structure and its relationship to genetic polymorphisms.
Human Esterase D demonstrates a distinct tissue distribution pattern, with highest expression levels detected in the liver and kidney . This distribution pattern aligns with its proposed role in detoxification processes, as these organs are primary sites for metabolism of xenobiotics and endogenous compounds.
While ESD shows prominence in liver and kidney, it should be noted that the related human carboxylesterase 2 (CES2) shows a somewhat different pattern, being expressed mainly in liver and intestine, but with highest abundance in intestinal tissues . This differential expression pattern between related esterases suggests specialized functions across different tissue types.
The expression pattern of ESD appears to be regulated by specific factors. Research has demonstrated that phenobarbital treatment can enhance ESD expression approximately 3-fold in certain cell lines, indicating responsiveness to xenobiotic inducers commonly associated with detoxification enzymes .
The purification of human Esterase D to biochemical homogeneity has been achieved through a multi-step chromatographic approach. The established protocol includes sequential chromatography using carboxymethylcellulose, phenyl-Sepharose, chromatofocusing, and hydroxylapatite columns . This comprehensive purification scheme yields approximately 10,000-fold purification of the enzyme with 15% recovery of total activity, demonstrating both high specificity and reasonable yield .
For characterization of ESD polymorphisms, specialized two-dimensional isoelectric focusing methods have been developed to identify the subunits from both homodimeric and heterodimeric forms . Additionally, one-dimensional isoelectric focusing under reducing and mild denaturing conditions has been employed to study the influence of dithiothreitol and low concentrations of urea on the focusing pattern of ESD dimers .
Immunological approaches have also been instrumental in ESD research. Both rabbit polyclonal and mouse monoclonal antibodies against ESD have been prepared that can recognize either denatured or native human ESD protein . These antibodies have proven valuable for immunoprecipitation studies, demonstrating their ability to precipitate a polypeptide with a molecular mass of about 33-34 kDa from various cell lines across different mammalian species .
Human Esterase D serves as an important genetic marker for retinoblastoma, a rare form of eye cancer primarily affecting children . The ESD gene is located on chromosome 13q14, in close proximity to the RB1 gene responsible for retinoblastoma. This physical linkage has made ESD a valuable marker for tracking deletions and other genetic alterations in this chromosomal region.
The purification of ESD to homogeneity and the development of specific antibodies against the enzyme have opened significant avenues for further research into this association. These tools facilitate cloning of the ESD gene and support more detailed studies of retinoblastomas . The availability of purified protein and specific antibodies enables researchers to investigate the potential functional relationship between ESD and retinoblastoma development.
While ESD itself is not believed to directly cause retinoblastoma, its use as a genetic marker has substantial clinical value in genetic screening and counseling for families with histories of this cancer. The polymorphic nature of ESD further enhances its utility as a genetic marker, as the different phenotypes can be distinguished using specialized electrophoretic techniques .
Human Esterase D exhibits genetic polymorphism in human populations, and several specialized techniques have been developed to identify and characterize these variants. A notable approach is the two-dimensional isoelectric focusing method, specifically developed to identify ESD subunits from both homodimeric and heterodimeric forms across five different ESD phenotypes .
Complementing this approach, one-dimensional isoelectric focusing under reducing and mild denaturing conditions has been employed to study how dithiothreitol and low concentrations of urea influence the focusing pattern of ESD dimers . These techniques provide critical insights into the structural basis of ESD polymorphism and how different conditions affect the enzyme's quaternary structure.
Immunological methods utilizing specific antibodies against ESD have also proven valuable in distinguishing polymorphic variants. Both polyclonal and monoclonal antibodies have been developed that can recognize either denatured or native human ESD protein . These antibodies facilitate the identification and characterization of different ESD variants through techniques such as Western blotting and immunoprecipitation.
Modern research on esterases has advanced significantly with the development of genetic knockout and transgenic models. While the search results don't specifically describe ESD knockout models, they provide valuable insights from related carboxylesterase research that can be applied to ESD studies.
The CRISPR-Cas9 technology has been successfully employed to delete carboxylesterase gene clusters in mice, as demonstrated with the Ces2 cluster genes . This approach could potentially be adapted for studying human ESD function through the creation of ESD knockout models. Verification of gene deletion can be performed using PCR analysis for the target genes and qRT-PCR to assess expression levels in relevant tissues .
Transgenic approaches have also been established, where human esterase genes can be expressed in mice lacking the corresponding mouse genes. For example, homozygous transgenic mice containing human CES2 cDNA expressed primarily in the liver or intestine have been generated in a mouse Ces2 cluster deletion background . Similar approaches could be applied to study human ESD function in vivo.
The expression of human esterases in specific tissues can be verified through various methods, including:
Western blotting with specific antibodies
Immunohistochemical staining
Analysis of crude membrane fractions from relevant tissues
The enzymatic activity of human Esterase D can be measured using specific substrates, with 4-methylumbelliferyl acetate being a well-established option . When using this substrate, researchers should consider the enzyme's Km value (approximately 10 × 10^-6 M) for experimental design and data interpretation .
Several factors can affect ESD activity measurements and should be carefully controlled:
The presence of sulfhydryl-reactive compounds: ESD activity is inhibited by p-chloromercuribenzoate and HgCl2, indicating that sulfhydryl (SH) groups are crucial for enzyme function . Therefore, the assay buffer should be free of compounds that might react with or oxidize thiol groups.
Sample preparation: Crude enzyme preparations versus purified enzyme will affect specific activity measurements. The established purification protocol involving carboxymethylcellulose, phenyl-Sepharose, chromatofocusing, and hydroxylapatite chromatographies can achieve a 10,000-fold purification of the enzyme with 15% recovery of total activity .
Phenotype considerations: Due to the polymorphic nature of ESD, samples from different individuals may show varying enzymatic properties. The homodimeric and heterodimeric forms of the enzyme should be considered when interpreting activity data .
Potential inducers: Research has shown that ESD expression can be enhanced by phenobarbital treatment . This induction potential should be considered when designing experiments, particularly those involving cell cultures or animal models.
Recent research on related carboxylesterases, particularly CES2, provides valuable insights that can be applied to ESD studies. The creation of Ces2 cluster knockout mice and subsequent humanization with human CES2 has demonstrated significant physiological effects that may have parallels in ESD function .
For instance, intestinal expression of human CES2 in Ces2 knockout mice has been shown to combat adverse effects of metabolic syndrome . This finding suggests that human esterases play critical roles in metabolic health that extend beyond simple xenobiotic metabolism. Given the biochemical similarities between CES2 and ESD, it is plausible that ESD may also influence metabolic parameters in ways not yet fully explored.
The tissue-specific effects observed with CES2 expression are particularly noteworthy. While liver expression of human CES2 in Ces2 knockout mice led to increased body weight and adipose tissue mass, intestinal expression had the opposite effect, leading to lower body weight . These tissue-specific differences highlight the importance of considering local versus systemic effects when studying esterases including ESD.
Additionally, the observation that Ces2 deficiency in male mice resulted in significant gonadal white adipose tissue inflammation (adipositis), which was effectively rescued by human CES2 expression particularly in the intestine , suggests that esterases may play important roles in inflammation regulation that could be relevant to ESD function as well.
Based on the available research, several challenges and opportunities exist in the field of human Esterase D research:
Challenges:
Distinguishing the specific physiological roles of ESD from other related carboxylesterases
Developing highly specific inhibitors or modulators of ESD activity for functional studies
Understanding the potential relationship between ESD function and retinoblastoma beyond genetic linkage
Elucidating the three-dimensional structure of ESD to facilitate structure-based drug design
Opportunities:
Leveraging modern genetic tools such as CRISPR-Cas9 to create precise ESD knockout models
Developing humanized mouse models expressing human ESD in specific tissues to study its function in vivo
Exploring the potential roles of ESD in metabolic health, inflammation, and detoxification
Investigating ESD polymorphisms as potential factors in varied drug responses or disease susceptibilities
The development of specific antibodies against human ESD provides valuable tools for these future studies. Additionally, the established purification protocols offer methods for obtaining pure enzyme for structural and functional investigations . The identification of ESD as a genetic marker for retinoblastoma continues to highlight its clinical relevance and potential for translational research .
Esterase D, also known as S-formylglutathione hydrolase, is a cytoplasmic serine hydrolase that belongs to the esterase D family. This enzyme plays a crucial role in the detoxification of formaldehyde and is involved in various metabolic processes. The human recombinant form of this enzyme is widely used in research and biotechnology.
Esterase D is a member of the hydrolase family, specifically those acting on thioester bonds. The enzyme catalyzes the hydrolysis of S-formylglutathione into glutathione and formic acid . This reaction is essential for the detoxification of formaldehyde, a toxic compound that can be generated during various metabolic processes.
The enzyme is active toward numerous substrates, including O-acetylated sialic acids, and may be involved in the recycling of sialic acids . This broad substrate specificity makes Esterase D a versatile enzyme with potential applications in various biochemical pathways.
The human recombinant form of Esterase D is produced using Escherichia coli as the expression system . The recombinant protein is typically purified using conventional chromatography techniques to achieve high purity levels. This recombinant enzyme is used in various research applications, including studies on enzyme kinetics, substrate specificity, and potential therapeutic uses.
Recombinant Esterase D is widely used in biochemical and clinical research. Its ability to hydrolyze a wide range of substrates makes it a valuable tool for studying metabolic pathways and enzyme mechanisms. Additionally, its role in detoxifying formaldehyde makes it an important enzyme for research on cellular detoxification processes.